7-103515258-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005045.4(RELN):​c.8046T>C​(p.His2682His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 1,613,780 control chromosomes in the GnomAD database, including 143,927 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 21989 hom., cov: 32)
Exomes 𝑓: 0.39 ( 121938 hom. )

Consequence

RELN
NM_005045.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -1.43

Publications

37 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
SLC26A5-AS1 (HGNC:55680): (SLC26A5 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 7-103515258-A-G is Benign according to our data. Variant chr7-103515258-A-G is described in ClinVar as Benign. ClinVar VariationId is 95230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.787 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005045.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RELN
NM_005045.4
MANE Select
c.8046T>Cp.His2682His
synonymous
Exon 50 of 65NP_005036.2
RELN
NM_173054.3
c.8046T>Cp.His2682His
synonymous
Exon 50 of 64NP_774959.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RELN
ENST00000428762.6
TSL:5 MANE Select
c.8046T>Cp.His2682His
synonymous
Exon 50 of 65ENSP00000392423.1
RELN
ENST00000424685.3
TSL:5
c.8046T>Cp.His2682His
synonymous
Exon 50 of 65ENSP00000388446.3
RELN
ENST00000343529.9
TSL:5
c.8046T>Cp.His2682His
synonymous
Exon 50 of 64ENSP00000345694.5

Frequencies

GnomAD3 genomes
AF:
0.504
AC:
76497
AN:
151894
Hom.:
21941
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.761
Gnomad AMI
AF:
0.323
Gnomad AMR
AF:
0.456
Gnomad ASJ
AF:
0.379
Gnomad EAS
AF:
0.808
Gnomad SAS
AF:
0.641
Gnomad FIN
AF:
0.354
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.358
Gnomad OTH
AF:
0.480
GnomAD2 exomes
AF:
0.463
AC:
116373
AN:
251162
AF XY:
0.461
show subpopulations
Gnomad AFR exome
AF:
0.773
Gnomad AMR exome
AF:
0.447
Gnomad ASJ exome
AF:
0.385
Gnomad EAS exome
AF:
0.805
Gnomad FIN exome
AF:
0.353
Gnomad NFE exome
AF:
0.357
Gnomad OTH exome
AF:
0.427
GnomAD4 exome
AF:
0.391
AC:
571285
AN:
1461768
Hom.:
121938
Cov.:
55
AF XY:
0.396
AC XY:
288107
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.773
AC:
25896
AN:
33480
American (AMR)
AF:
0.450
AC:
20099
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.387
AC:
10118
AN:
26136
East Asian (EAS)
AF:
0.796
AC:
31613
AN:
39698
South Asian (SAS)
AF:
0.608
AC:
52481
AN:
86256
European-Finnish (FIN)
AF:
0.354
AC:
18882
AN:
53410
Middle Eastern (MID)
AF:
0.421
AC:
2426
AN:
5768
European-Non Finnish (NFE)
AF:
0.345
AC:
383690
AN:
1111940
Other (OTH)
AF:
0.432
AC:
26080
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
20759
41519
62278
83038
103797
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12582
25164
37746
50328
62910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.504
AC:
76615
AN:
152012
Hom.:
21989
Cov.:
32
AF XY:
0.507
AC XY:
37704
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.762
AC:
31581
AN:
41470
American (AMR)
AF:
0.457
AC:
6975
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.379
AC:
1314
AN:
3470
East Asian (EAS)
AF:
0.807
AC:
4154
AN:
5146
South Asian (SAS)
AF:
0.642
AC:
3092
AN:
4818
European-Finnish (FIN)
AF:
0.354
AC:
3736
AN:
10564
Middle Eastern (MID)
AF:
0.429
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
0.358
AC:
24320
AN:
67962
Other (OTH)
AF:
0.485
AC:
1022
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1704
3408
5113
6817
8521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.406
Hom.:
28442
Bravo
AF:
0.517
Asia WGS
AF:
0.746
AC:
2595
AN:
3478
EpiCase
AF:
0.362
EpiControl
AF:
0.355

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 03, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Norman-Roberts syndrome Benign:3
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.11
DANN
Benign
0.55
PhyloP100
-1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229864; hg19: chr7-103155705; COSMIC: COSV100632618; COSMIC: COSV100632618; API